Brief: Dr Reddy's Says Receives U.S. FDA Approval For Rituximab Biosimilar
01/08/2026 05:16
BRIEF-Dr Reddy's Says Receives U.S. FDA Approval For Rituximab Biosimilar Aug 1 (Reuters) - Dr Reddy's Laboratories Ltd REDY.NS:
DR REDDY'S - RECEIVES U.S. FDA APPROVAL FOR RITUXIMAB BIOSIMILAR
Source text: ID:nBSE6lpY3R
Further company coverage: REDY.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption